GERN FY 2010 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+106.4% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$111M-3120.0% margin

Net Income

-$111M-3125.9% margin

EPS (Diluted)

$-1.14

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$45M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$234M

Total Liabilities

$41M

Stockholders' Equity

$193M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+106.4%
Gross Profit	$4M	$2M	+106.4%
Operating Income	-$111M	-$70M	-58.3%
Net Income	-$111M	-$70M	-58.7%